11/01/2021
Among patients receiving chemotherapy, symptom monitoring with electronic patient-reported outcomes (ePROs) is associated with improved clinical outcomes, satisfaction, and compliance with therapy. Debra Patt, M.D., Ph.D., MBA, medical oncologist, and executive vice president, public policy, payer relations, and strategic initiatives at Texas Oncology and Amila Patel, Pharm.D., oncology pharmacist and chief clinical officer at Navigating Cancer, provided insights on the implementation and effectiveness of ePROs for patients with cancer.